GLP-1s and eye safety are a hot clinical topic, and I was looking for some reassurance by attending the symposium entitled Are GLP-1s Receptor Agonists Safe for the Eyes? at the American Diabetes Association 86th Scientific Sessions in New Orleans
Clinics offering IV glutathione for cosmetic use are now in legally uncertain territory and face potential regulatory action
the dual-agonist reached ~20% at 72 weeks at the highest dose
It is currently available as a 2 mg, 4 mg, 8 mg, and 12 mg injection that can be administered once weekly
Under Agency policy, the Application Holder (drug sponsor) is ultimately responsible for cGMP compliance, even at a CDMO or CMO site
But semaglutide the active pharmaceutical ingredient in Wegovy is widely available, says Scott Brunner, CEO of the Alliance for Pharmacy Compounding